Publication

Article Metrics

Citations


Online attention

Structural and biochemical characterization of botulinum neurotoxin subtype B2 binding to its receptors

DOI: 10.3390/toxins12090603 DOI Help

Authors: Jonathan R. Davies (Stockholm University) , Geoffrey Masuyer (Stockholm University; University of Bath) , Pal Stenmark (Stockholm University; Lund University)
Co-authored by industrial partner: No

Type: Journal Paper
Journal: Toxins , VOL 12

State: Published (Approved)
Published: September 2020
Diamond Proposal Number(s): 15806

Open Access Open Access

Abstract: Botulinum neurotoxins (BoNTs) can be used therapeutically to treat a wide range of neuromuscular and neurological conditions. A collection of natural BoNT variants exists which can be classified into serologically distinct serotypes (BoNT/B), and further divided into subtypes (BoNT/B1, B2, …). BoNT subtypes share a high degree of sequence identity within the same serotype yet can display large variation in toxicity. One such example is BoNT/B2, which was isolated from Clostridium botulinum strain 111 in a clinical case of botulism, and presents a 10-fold lower toxicity than BoNT/B1. In an effort to understand the molecular mechanisms behind this difference in potency, we here present the crystal structures of BoNT/B2 in complex with the ganglioside receptor GD1a, and with the human synaptotagmin I protein receptor. We show, using receptor-binding assays, that BoNT/B2 has a slightly higher affinity for GD1a than BoNT/B1, and confirm its considerably weaker affinity for its protein receptors. Although the overall receptor-binding mechanism is conserved for both receptors, structural analysis suggests the lower affinity of BoNT/B2 is the result of key substitutions, where hydrophobic interactions important for synaptotagmin-binding are replaced by polar residues. This study provides a template to drive the development of future BoNT therapeutic molecules centered on assessing the natural subtype variations in receptor-binding that appears to be one of the principal stages driving toxicity.

Journal Keywords: Clostridium botulinum; botulism; botulinum neurotoxin; BoNT/B; synaptotagmin; ganglioside

Subject Areas: Biology and Bio-materials, Chemistry, Medicine


Instruments: I04-Macromolecular Crystallography

Documents:
toxins-12-00603-v2.pdf

Discipline Tags:



Technical Tags: